Xinbo Qiao

The share of this author’s assessed papers carrying a ⚑ flag. A concentration is a prompt for expert review — never, on its own, a determination about the person.

Collaborators, sized by shared output and coloured by their own reproducibility (green = high, red = low). Click a node to open their card. A pattern is a prompt for review, never a determination.

How this author’s assessed papers reproduced — the outcome of reproduction attempts, not a judgement of the person. Coverage is partial and grows over time.

Assessed papers (1)

• NUSAP1 Could be a Potential Target for Preventing NAFLD Progression to Liver Cancer.⚑
  2022 L1 45/100 ⚑

1 assessed by us (0 reproduced) · 42 not yet assessed — every PubMed paper on record, linked below.

• Inhibiting TRIM21 Neddylation Rejuvenates Oocyte Quality in PCOS by Regulating Ubiquitination of CPT1A ↗

  Research · 2026 · PMID 41939244
  not yet assessed
• From PCOS to PMOS: perspectives on the new nomenclature ↗

  The Lancet · 2026 · PMID 42392098
  not yet assessed
• Correction: Targeting SOST using a small‑molecule compound retards breast cancer bone metastasis ↗

  Molecular Cancer · 2025 · PMID 40241133
  not yet assessed
• Erratum to: FSIP1 enhances the therapeutic sensitivity to CDK4/6 inhibitors in triple-negative breast cancer patients by activating the Nanog pathway ↗

  Science China Life Sciences · 2025 · PMID 40549239
  not yet assessed
• Correction: CMTM6 overexpression confers trastuzumab resistance in HER2‑positive breast cancer ↗

  Molecular Cancer · 2025 · PMID 40229879
  not yet assessed
• Correction: Binding blockade between TLN1 and integrin β1 represses triple-negative breast cancer ↗

  eLife · 2025 · PMID 40338227
  not yet assessed
• Erratum to “A highly potent small-molecule antagonist of exportin-1 selectively eliminates CD44+ CD24- enriched breast cancer stem-like cells” [Drug Resist. Updates 66 (2023) 100903] ↗

  Drug Resistance Updates · 2025 · PMID 40912935
  not yet assessed
• Correction: Association of human breast cancer CD44-/CD24- cells with delayed distant metastasis ↗

  eLife · 2025 · PMID 40928840
  not yet assessed
• <i>CEMIP</i> as a potential biomarker and therapeutic target for breast cancer patients: Erratum ↗

  International Journal of Medical Sciences · 2025 · PMID 41049451
  not yet assessed
• Epigenetics-targeted drugs: current paradigms and future challenges ↗

  Signal Transduction and Targeted Therapy · 2024 · PMID 39592582
  not yet assessed
• Correction: CMTM6 overexpression confers trastuzumab resistance in HER2‑positive breast cancer ↗

  Molecular Cancer · 2024 · PMID 38183152
  not yet assessed
• CMTM6 overexpression confers trastuzumab resistance in HER2-positive breast cancer ↗

  Molecular Cancer · 2023 · PMID 36627608
  not yet assessed
• KK-LC-1 as a therapeutic target to eliminate ALDH+ stem cells in triple negative breast cancer ↗

  Nature Communications · 2023 · PMID 37147285
  not yet assessed
• FSIP1 enhances the therapeutic sensitivity to CDK4/6 inhibitors in triple-negative breast cancer patients by activating the Nanog pathway ↗

  Science China Life Sciences · 2023 · PMID 37460715
  not yet assessed
• KCNJ15 deficiency promotes drug resistance via affecting the function of lysosomes ↗

  Asian Journal of Pharmaceutical Sciences · 2023 · PMID 37274925
  not yet assessed
• Efficacy and safety of endocrine therapy after mastectomy in patients with hormone receptor positive breast ductal carcinoma in situ: Retrospective cohort study ↗

  eLife · 2023 · PMID 36745010
  not yet assessed
• KK-LC-1 as a therapeutic target to eliminate ALDH+ stem cells in triple negative breast cancer ↗

  Figshare · 2023
  not yet assessed
• Targeting SOST using a small-molecule compound retards breast cancer bone metastasis ↗

  Molecular Cancer · 2022 · PMID 36581888
  not yet assessed
• A highly potent small-molecule antagonist of exportin-1 selectively eliminates CD44+CD24- enriched breast cancer stem-like cells ↗

  Drug Resistance Updates · 2022 · PMID 36463808
  not yet assessed
• Mosaic gradient histogram for object tracking in DoFP infrared polarization imaging ↗

  ISPRS Journal of Photogrammetry and Remote Sensing · 2022
  not yet assessed
• NUSAP1 Could be a Potential Target for Preventing NAFLD Progression to Liver Cancer⚑

  Frontiers in Pharmacology · 2022 · PMID 35431924
  L1 45/100 ⚑
• Dalpiciclib partially abrogates ER signaling activation induced by pyrotinib in HER2+HR+ breast cancer ↗

  eLife · 2022 · PMID 36602226
  not yet assessed
• <i>CEMIP</i> as a potential biomarker and therapeutic target for breast cancer patients ↗

  International Journal of Medical Sciences · 2022 · PMID 35370456
  not yet assessed
• Author response: Binding blockade between TLN1 and integrin β1 represses triple-negative breast cancer ↗

  2022
  not yet assessed
• Oxytocin Inhibits Breast Cancer Proliferation and Migration by Regulating the UlLK1/Autophagy Axis ↗

  SSRN Electronic Journal · 2022
  not yet assessed
• Efficacy and safety of endocrine therapy after mastectomy in patients with hormone receptor positive breast ductal carcinoma in situ:retrospective cohort study ↗

  medRxiv · 2022
  not yet assessed
• Dalpiciclib Partially Abrogates ER Signaling Activation Induced by Pyrotinib In HER2 ⁺ HR ⁺ Breast Cancer ↗

  bioRxiv (Cold Spring Harbor Laboratory) · 2022
  not yet assessed
• Long-Term Outcomes by Neoadjuvant Efficacy Indexes in Patients with HR and HR /HER2 Breast Cancer after Neoadjuvant Systemic Therapy: A Systematic Review and Meta-Analysis ↗

  SSRN Electronic Journal · 2022
  not yet assessed
• Author response: Dalpiciclib partially abrogates ER signaling activation induced by pyrotinib in HER2+HR+ breast cancer ↗

  2022
  not yet assessed
• Author response: Efficacy and safety of endocrine therapy after mastectomy in patients with hormone receptor positive breast ductal carcinoma in situ: Retrospective cohort study ↗

  2022
  not yet assessed
• Binding blockade between TLN1 and integrin β1 represses triple-negative breast cancer ↗

  eLife · 2022 · PMID 35285795
  not yet assessed
• Association of human breast cancer CD44-/CD24- cells with delayed distant metastasis ↗

  eLife · 2021 · PMID 34318746
  not yet assessed
• Polarization Gradient Histogram for Object Tracking in Infrared Polarization Imaging ↗

  2021
  not yet assessed
• Dalpiciclib and Pyrotinib Exert Synergistic Antitumor Effects in Triple Positive Breast Cancer ↗

  bioRxiv (Cold Spring Harbor Laboratory) · 2021
  not yet assessed
• Author response: Association of human breast cancer CD44-/CD24- cells with delayed distant metastasis ↗

  2021
  not yet assessed
• <i>HCK</i> can serve as novel prognostic biomarker and therapeutic target for Breast Cancer patients ↗

  International Journal of Medical Sciences · 2020 · PMID 33162805
  not yet assessed
• LIPH promotes metastasis by enriching stem‐like cells in triple‐negative breast cancer ↗

  Journal of Cellular and Molecular Medicine · 2020 · PMID 32618099
  not yet assessed
• FSIP2 can serve as a predictive biomarker for Clear Cell Renal Cell Carcinoma prognosis ↗

  International Journal of Medical Sciences · 2020 · PMID 33162809
  not yet assessed
• Clinical Implications of <i>HSC70</i> Expression in Clear Cell Renal Cell Carcinoma ↗

  International Journal of Medical Sciences · 2020 · PMID 33390792
  not yet assessed
• Association of CD44 ⁻ /CD24 ⁻ Breast Cancer Cells with Late Stage Tumor Recurrence ↗

  bioRxiv (Cold Spring Harbor Laboratory) · 2020
  not yet assessed
• Neoadjuvant Chemotherapy Plays an Adverse Role in the Prognosis of Grade 2 Breast Cancer ↗

  Journal of Cancer · 2019 · PMID 31737103
  not yet assessed
• Breast-Shape Classification and Implant Construction Method for Unilateral Breast Reconstruction ↗

  IEEE Access · 2019
  not yet assessed
• The effects of beta-blocker use on cancer prognosis: a meta-analysis based on 319,006 patients ↗

  OncoTargets and Therapy · 2018 · PMID 30174436
  not yet assessed